Košík

0498983 - ÚŽFG 2019 RIV GB eng A - Abstrakt
Rohiwal, Sonali Suresh - Klíma, Jiří - Vaškovičová, Michaela - Šenigl, Filip - Šlouf, Miroslav - Pavlova, Ewa - Štěpánek, Petr - Stieger, K. - Ellederová, Zdeňka
NANOPARTICLE BASED CRSIPR/CAS GENE EDITING SYSTEM TO TREAT HUNTINGTON'S DISEASE.
Journal of Neurology Neurosurgery and Psychiatry. Roč. 89, S1 (2018), A90-A91. ISSN 0022-3050. E-ISSN 1468-330X.
[Plenary Meeting of the European Huntington´s Disease Network (EHDN). 14.09.2018-16.09.2018, Vienna]
Grant CEP: GA MŠMT(CZ) LO1609
Institucionální podpora: RVO:67985904 ; RVO:61389013 ; RVO:68378050
Klíčová slova: Huntington´s disease * gene therapy
Obor OECD: Genetics and heredity (medical genetics to be 3); Polymer science (UMCH-V)
Trvalý link: http://hdl.handle.net/11104/0291267